On the role of G protein-coupled receptors oligomerization

Open Biology Journal

Volumn 4, Issue , 2011, Pages 47-53

  Gómez Soler, Maricel ^a   Ahern, Siobhán ^a   Fernández Dueñas, Víctor ^a   Ciruela, Francisco ^a,b  

^a Unitat de Bioquimica   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

G protein coupled receptor; GPCR oligomerization; Protein protein interaction

Indexed keywords

EID: 84855842470     PISSN: None     EISSN: 18741967     Source Type: Journal    
DOI: 10.2174/1874196701104010047     Document Type: Article

References (74)

1. Agnati LF, Fuxe K, Zini I, Lenzi P, Hokfelt T. Aspects on receptor regulation and isoreceptor identification. Med Biol 1980; 58: 182-7.
2. 2- adrenergic receptors in the central nervous system. Science 1980; 207: 645-7.
3. Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 2003; 55: 509-50.
4. Avissar S, Amitai G, Sokolovsky M. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high-and low-affinity agonist states. Proc Natl Acad Sci U S A 1983; 80: 156-9.
5. 2- adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. Biochem Biophys Res Commun 1982; 109: 21-9.
6. Peterson GL, Rosenbaum LC, Broderick DJ, Schimerlik MI. Physical properties of the purified cardiac muscarinic acetylcholine receptor. Biochemistry 1986; 25: 3189-202.
7. Herberg JT, Codina J, Rich KA, Rojas FJ, Iyengar R. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor. J Biol Chem 1984; 259: 9285-94.
8. Ng GY, George SR, Zastawny RL, et al. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry 1993; 32: 11727-33.
9. 1 receptor. Eur J Pharmacol 1994; 267: 7-19.
10. 2L dopamine receptor in Sf9 cells. J Neurochem 1994; 63: 1589-95.
11. 2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 1996; 227: 200-4.
12. George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GY, O'Dowd BF. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem 1998; 273: 30244-8.
13. Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF, George SR. Dopamine D2 receptor dimers in human and rat brain. FEBS Lett 1998; 441: 383-6.
14. 1 adenosine receptors in brain cortex. J Neurosci Res 1995; 42: 818-28.
15. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001; 2: 274-86.
16. Franco R, Canals M, Marcellino D, Ferre S, Agnati L, Mallol J, Casado V, Ciruela F, Fuxe K, Lluis C, Canela EI. Regulation of heptaspanning-membrane- receptor function by dimerization and clustering. Trends Biochem Sci 2003; 28: 238-43.
17. Milligan G, Bouvier M. Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J 2005; 272: 2914-25.
18. Pfleger KD, Eidne KA. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 2006; 3: 165-74.
19. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 2007; 104: 654-9.
20. Juhasz JR, Hasbi A, Rashid AJ, So CH, George SR, O'Dowd BF. μ-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur J Pharmacol 2008; 581: 235-43.
21. Carriba P, Navarro G, Ciruela F, Ferre S, Casado V, Agnati L, Cortes A, Mallol J, Fuxe K, Canela EI, Lluis C, Franco R. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 2008; 5: 727-33.
22. Gandia J, Galino J, Amaral OB, Soriano A, Lluis C, Franco R, Ciruela F. Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique. FEBS Lett 2008; 582: 2979-84.
23. Dupre DJ, Robitaille M, Ethier N, Villeneuve LR, Mamarbachi AM, Hebert TE. Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. J Biol Chem 2006; 281: 34561-73.
24. Guo W, Urizar E, Kralikova M, Mobarec JC, Shi L, Filizola M, Javitch JA. Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 2008; 27: 2293-304.
25. 1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 2007; 71: 1015-29.
26. 2A Gprotein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. Sci World J 2008; 8: 1088-97.
27. Vidi PA, Chen J, Irudayaraj JM, Watts VJ. Adenosine A2A receptors assemble into higher-order oligomers at the plasma membrane. FEBS Lett 2008; 582: 3985-90.
28. Chabre M, Cone R, Saibil H. Biophysics: is rhodopsin dimeric in native retinal rods? Nature 2003; 426: 30,1; discussion 31.
29. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH. Heterodimerization is required for the formation of a functional GABAB receptor. Nature 1998; 396: 679-82.
30. Fotiadis D, Jastrzebska B, Philippsen A, Muller DJ, Palczewski K, Engel A. Structure of the rhodopsin dimer: a working model for G protein-coupled receptors. Curr Opin Struct Biol 2006; 16: 252-9.
31. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996; 271: 16384-92.
32. Lee SP, O'Dowd BF, Rajaram RD, Nguyen T, George SR. D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry 2003; 42: 11023-31.
33. Guo W, Shi L, Javitch JA. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 2003; 278: 4385-8.
34. Guo W, Shi L, Filizola M, Weinstein H, Javitch JA. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci U S A 2005; 102: 17495-500.
35. 2c receptor. EMBO Rep 2008; 9: 363-9.
36. 4 receptor dimerization. Biochem Biophys Res Commun 2007; 356: 642-7.
37. Hernanz-Falcon P, Rodriguez-Frade JM, Serrano A, et al. Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 2004; 5: 216-23.
38. Wang HX, Konopka JB. Identification of amino acids at two dimer interface regions of the alpha-factor receptor (Ste2). Biochemistry 2009; 48: 7132-9.
39. Mikhailova MV, Blansett J, Jacobi S, Mayeux PR, Cornett LE. Transmembrane domain IV of the Gallus gallus VT2 vasotocin receptor is essential for forming a heterodimer with the corticotrophin releasing hormone receptor. J Biomed Opt 2008; 13: 031208.
40. Gonzalez-Maeso J, Ang RL, Yuen T, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008; 452: 93-7.
41. Filizola M. Increasingly accurate dynamic molecular models of G protein-coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery? Life Sci 2010; 86: 590-7.
42. Fonseca JM, Lambert NA. Instability of a class a G protein-coupled receptor oligomer interface. Mol Pharmacol 2009; 75: 1296-9.
43. 2 receptors. Anal Chem 2004; 76: 5354-63.
44. 2R. Biochem Biophys Res Commun 2010; 394: 222-7.
45. 5 muscarinic acetylcholine receptor third intracellular loop regulates receptor function and oligomerization. Biochim Biophys Acta 2010; 1803: 813-25.
46. Agnati LF, Guidolin D, Leo G, Carone C, Genedani S, Fuxe K. Receptor-receptor interactions: A novel concept in brain integration. Prog Neurobiol 2010; 90: 157-75.
47. Petaja-Repo UE, Hogue M, Laperriere A, Walker P, Bouvier M. Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem 2000; 275: 13727-36.
48. Petaja-Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, Bouvier M. Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 2001; 276: 4416-23.
49. Reddy PS, Corley RB. Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. Bioessays 1998; 20: 546-54.
50. BR2. Nature 1998; 396: 674-9.
51. Kaupmann K, Schuler V, Mosbacher J, Bischoff S, Bittiger H, Heid J, Froestl W, Leonhard S, Pfaff T, Karschin A, Bettler B. Human gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K+ channels. Proc Natl Acad Sci U S A 1998; 95: 14991-6.
52. B receptor function. Science 1999; 283: 74-7.
53. B receptors uncovers similarity to metabotropic glutamate receptors. Nature 1997; 386: 239-46.
54. B receptors. Nature 1997; 386: 223-4.
55. B receptor. Biochem Biophys Res Commun 1998; 253: 10-5.
56. BR1 receptor. Eur J Neurosci 1999; 11: 2874-82.
57. 2+ current in sympathetic neurons. J Neurosci 2000; 20: 2867-74.
58. B1 splice variant encoding a truncated receptor. J Biol Chem 2000; 275: 32174-81.
59. Briddon SJ, Gandia J, Amaral OB, et al. Plasma membrane diffusion of G protein-coupled receptor oligomers. Biochim Biophys Acta 2008; 1783: 2262-8.
60. Briddon SJ, Hill SJ. Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes. Trends Pharmacol Sci 2007; 28: 637-45.
61. 1b- adrenoceptors coexpressed in human embryonic kidney 293 cells. J Pharmacol Exp Ther 2004; 309: 259-66.
62. 3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinase signalling pathways in Chinese hamster ovary cells. Br J Pharmacol 2003; 138: 1340-50.
63. 2 receptors results in cooperative regulation of cyclic AMP accumulation and mitogen-activated protein kinase activity. Mol Cell Biol 2001; 21: 8452-60.
64. 3 cells changes the functional response to micro agonists from inhibitory to excitatory. Mol Pharmacol 2003; 63: 89-95.
65. 2A-adrenergic receptors. Mol Pharmacol 2003; 64: 1317-24.
66. 2A-adrenergic and μ-opioid receptors controls cell signaling. Nat Chem Biol 2008; 4: 126-31.
67. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, et al. Chemokine receptor homo-or heterodimerization activates distinct signaling pathways. EMBO J 2001; 20: 2497-507.
68. Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati LF. Heterodimers and receptor mosaics of different types of G-proteincoupled receptors. Physiology (Bethesda) 2008; 23: 322-32.
69. Waldhoer M, Fong J, Jones RM, et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 2005; 102: 9050-5.
70. Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399: 697-700.
71. Berque-Bestel I, Lezoualc'h F, Jockers R. Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers. Curr Drug Discov Technol 2008; 5: 312-8.
72. Daniels DJ, Lenard NR, Etienne CL, Law PY, Roerig SC, Portoghese PS. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A 2005; 102: 19208-13.
73. Barki-Harrington L, Perrino C, Rockman HA. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc Res 2004; 63: 391-402.
74. 1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001; 7: 1003-9.